A high incidence of vertebral fracture in women with breast cancer
Open Access
- 12 February 1999
- journal article
- clinical trial
- Published by Springer Science and Business Media LLC in British Journal of Cancer
- Vol. 79 (7), 1179-1181
- https://doi.org/10.1038/sj.bjc.6690188
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Oral Clodronate and Reduction in Loss of Bone Mineral Density in Women With Operable Primary Breast CancerJNCI Journal of the National Cancer Institute, 1998
- Guidelines for diagnosis and management of osteoporosisOsteoporosis International, 1997
- Chemical castration induced by adjuvant cyclophosphamide, methotrexate, and fluorouracil chemotherapy causes rapid bone loss that is reduced by clodronate: a randomized study in premenopausal breast cancer patients.Journal of Clinical Oncology, 1997
- Clodronate decreases the frequency of skeletal metastases in women with breast cancerBone, 1996
- Cyclical intravenous clodronate in postmenopausal osteoporosis: Results of a long-term Clinical trialBone, 1996
- Histomorphometric evidence for osteoclast-mediated bone resorption in metastatic breast cancerBone, 1994
- Prevalence of vertebral fracture in women and the relationship with bone density and symptoms: The chingford studyJournal of Bone and Mineral Research, 1993
- The assessment of vertebral deformity: A method for use in population studies and clinical trialsOsteoporosis International, 1993
- Localization of parathyroid hormone-related protein in breast cancer metastases: increased incidence in bone compared with other sites.1991
- Risk of osteoporotic fractures in women with breast cancer: A population-based cohort studyJournal of Chronic Diseases, 1987